← Back to patent-cliff list
硫酸阿扎那韦
Tier C — Watch / tradeAtazanavir Sulfate
百时美施贵宝
Originator
2003
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：HIV-1 protease
Brand：锐艾妥、Reyataz
Indications (approved)：HIV感染
Regional status
US
批准上市
2003-06-20
EU
批准上市
2004-03-01
China
批准上市
2005-05-13
Japan
批准上市
2003-12-18
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Atazanavir Sulfate?
Approved indications include: HIV感染.
When does the Atazanavir Sulfate patent expire?
No public expiry year is available for Atazanavir Sulfate yet; this page updates once verified.
How do I get a quote for Atazanavir Sulfate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25